1. Pro-oxidant and pro-apoptotic activity of polyphenol extract from Annurca apple and its underlying mechanisms in human breast cancer cells.
- Author
-
D'Angelo S, Martino E, Ilisso CP, Bagarolo ML, Porcelli M, and Cacciapuoti G
- Subjects
- Apoptosis drug effects, Breast Neoplasms pathology, Caspases genetics, Cell Cycle Checkpoints drug effects, Cell Proliferation drug effects, Chlorogenic Acid chemistry, Female, Flavonoids chemistry, Gene Expression Regulation, Neoplastic drug effects, Humans, MAP Kinase Signaling System drug effects, MCF-7 Cells, Malus chemistry, Plant Extracts chemistry, Reactive Oxygen Species chemistry, Tannins chemistry, Breast Neoplasms drug therapy, Chlorogenic Acid administration & dosage, Flavonoids administration & dosage, Plant Extracts administration & dosage, Reactive Oxygen Species administration & dosage, Tannins administration & dosage
- Abstract
Among nutraceuticals, polyphenols represent the most intriguing and studied class of compounds that can be therapeutics for a large spectrum of the most common diseases, including cancer. Although polyphenols are well known as potent antioxidants, a pro-oxidant effect has been associated with a pro-apoptotic function of these compounds in various types of tumor cells. Annurca apple, a southern Italian variety, is characterized by an extremely high content of polyphenols and displays a stronger antioxidant activity compared with other varieties. In the present study we explored the antiproliferative effect of Annurca apple polyphenol extract (APE) in human breast cancer MCF-7 cells and we investigated the underlying mechanisms. Results showed that at 500 µM catechin equivalent (EqC) APE acts as a pro-oxidant increasing thiobarbituric acid-reactive species cell content of approximately 6-fold more than the untreated cells. We found that APE strongly inhibits the proliferation of MCF-7 cells by inducing G2/M cell cycle arrest and apoptosis. Immunoblot analysis demonstrated that APE treatment increases the levels of p53 and p21, downregulates the expression of the cell cycle regulatory protein cyclin D1, and inhibits ERK1/2 phosphorylation. Moreover, APE treatment caused a marked increase of pro-apoptotic Bax/Bcl-2 ratio paralleled by caspase-9, -6, -7, and poly(ADP ribose) polymerase cleavage. Altogether our data indicate that APE, at elevated concentrations, acts as a potent pro-oxidant and antiproliferative agent able to downregulate ERK1/2 pathway leading to cell cycle inhibition and apoptosis and provides a rationale for its potential use in the development of novel therapeutics towards breast cancer.
- Published
- 2017
- Full Text
- View/download PDF